Dr. Margaret Herridge said looking at COVID-19 "across the spectrum" of patients is a key part of her new research: the Canadian COVID-19 Prospective Cohort Study (CANCOV). It is the first study in Canada to assess health outcomes for COVID-19 patients over a one-year period.
Led by Herridge and her co-lead Dr. Angela Cheung, more than 100 investigators across the country aim to evaluate 2,000 COVID-19 survivors and their family caregivers, testing things like their ability to carry out daily activities, cognitive capabilities and mental health.